Paychex Guides FY23 Adj. EPS Above View As Q4 Results Top Estimates

While reporting financial results for the fourth quarter and fiscal 2022 on Thursday, payroll and HR services provider Paychex Inc. (PAYX) initiated adjusted earnings guidance for the full year 2023, above analysts' estimates.

For fiscal 2023, the company now projects adjusted earnings per share to grow in the range of 9 to 10 percent on total revenues growth of 7 to 8 percent.

Based adjusted earnings of $3.77 per share and total revenues of $4.55 billion reported for fiscal 2022, the guidance implies adjusted earnings in a range of $4.11 to $4.15 per share on total revenues between $4.87 billion and $4.91 billion for fiscal 2023.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.06 per share on revenue growth of 7.5 percent to $4.88 billion for the year. Analysts' estimates typically exclude special items.

For the fourth quarter, the company reported net income of $296.4 million or $0.82 per share, up from $263.0 million or $0.73 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter were $0.81 per share, compared to $0.72 per share in the year-ago quarter.

Total revenue for the quarter increased 11 percent to $1.14 billion from $1.03 billion in the same quarter last year.

The Street was looking for earnings of $0.79 per share on revenues of $1.11 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT